• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价混合反演规划和优化(HIPO)算法在实时、高剂量率(HDR)近距离治疗前列腺中的优化应用。

Evaluation of hybrid inverse planning and optimization (HIPO) algorithm for optimization in real-time, high-dose-rate (HDR) brachytherapy for prostate.

机构信息

Premier Oncology, Fort Myers, FL 33966, USA.

出版信息

J Appl Clin Med Phys. 2013 Jul 8;14(4):4198. doi: 10.1120/jacmp.v14i4.4198.

DOI:10.1120/jacmp.v14i4.4198
PMID:23835384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5714541/
Abstract

The purpose of this study is to investigate the effectiveness of the HIPO planning and optimization algorithm for real-time prostate HDR brachytherapy. This study consists of 20 patients who underwent ultrasound-based real-time HDR brachytherapy of the prostate using the treatment planning system called Oncentra Prostate (SWIFT version 3.0). The treatment plans for all patients were optimized using inverse dose-volume histogram-based optimization followed by graphical optimization (GRO) in real time. The GRO is manual manipulation of isodose lines slice by slice. The quality of the plan heavily depends on planner expertise and experience. The data for all patients were retrieved later, and treatment plans were created and optimized using HIPO algorithm with the same set of dose constraints, number of catheters, and set of contours as in the real-time optimization algorithm. The HIPO algorithm is a hybrid because it combines both stochastic and deterministic algorithms. The stochastic algorithm, called simulated annealing, searches the optimal catheter distributions for a given set of dose objectives. The deterministic algorithm, called dose-volume histogram-based optimization (DVHO), optimizes three-dimensional dose distribution quickly by moving straight downhill once it is in the advantageous region of the search space given by the stochastic algorithm. The PTV receiving 100% of the prescription dose (V100) was 97.56% and 95.38% with GRO and HIPO, respectively. The mean dose (D(mean)) and minimum dose to 10% volume (D10) for the urethra, rectum, and bladder were all statistically lower with HIPO compared to GRO using the student pair t-test at 5% significance level. HIPO can provide treatment plans with comparable target coverage to that of GRO with a reduction in dose to the critical structures.

摘要

本研究旨在探讨 HIPO 计划和优化算法在实时前列腺 HDR 近距离治疗中的效果。本研究共纳入 20 例接受基于超声的实时 HDR 近距离治疗前列腺的患者,使用名为 Oncentra Prostate(SWIFT 版本 3.0)的治疗计划系统。所有患者的治疗计划均采用基于逆剂量-体积直方图的优化,然后实时进行图形优化(GRO)。GRO 是对等剂量线进行逐片手动操作。计划质量严重依赖于计划者的专业知识和经验。所有患者的数据均在后期检索,使用 HIPO 算法创建和优化治疗计划,该算法使用与实时优化算法相同的剂量限制、导管数量和轮廓集。HIPO 算法是一种混合算法,因为它结合了随机和确定性算法。随机算法称为模拟退火,用于搜索给定剂量目标集的最佳导管分布。确定性算法称为基于剂量-体积直方图的优化(DVHO),一旦进入随机算法给定的搜索空间的优势区域,它会快速优化三维剂量分布。接受 100%处方剂量(V100)的 PTV 分别为 GRO 和 HIPO 的 97.56%和 95.38%。与 GRO 相比,使用学生配对 t 检验,HIPO 可使尿道、直肠和膀胱的平均剂量(D(mean))和 10%体积最小剂量(D10)均统计学降低,差异有统计学意义(P<0.05)。与 GRO 相比,HIPO 可提供具有可比性的靶区覆盖的治疗计划,同时降低关键结构的剂量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/3f72d4e90d0a/ACM2-14-096-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/cbcb977433c2/ACM2-14-096-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/e73a71afa80d/ACM2-14-096-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/df16090b8532/ACM2-14-096-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/53bd81e14fc5/ACM2-14-096-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/18391be40ec1/ACM2-14-096-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/2d52b1fe888c/ACM2-14-096-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/17d1190fb3db/ACM2-14-096-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/5ed770edcecf/ACM2-14-096-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/3f72d4e90d0a/ACM2-14-096-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/cbcb977433c2/ACM2-14-096-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/e73a71afa80d/ACM2-14-096-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/df16090b8532/ACM2-14-096-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/53bd81e14fc5/ACM2-14-096-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/18391be40ec1/ACM2-14-096-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/2d52b1fe888c/ACM2-14-096-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/17d1190fb3db/ACM2-14-096-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/5ed770edcecf/ACM2-14-096-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bcc/5714541/3f72d4e90d0a/ACM2-14-096-g009.jpg

相似文献

1
Evaluation of hybrid inverse planning and optimization (HIPO) algorithm for optimization in real-time, high-dose-rate (HDR) brachytherapy for prostate.评价混合反演规划和优化(HIPO)算法在实时、高剂量率(HDR)近距离治疗前列腺中的优化应用。
J Appl Clin Med Phys. 2013 Jul 8;14(4):4198. doi: 10.1120/jacmp.v14i4.4198.
2
Comparison of dose and catheter optimization algorithms in prostate high-dose-rate brachytherapy.前列腺高剂量率近距离放射治疗中剂量与导管优化算法的比较
Brachytherapy. 2016 Jan-Feb;15(1):102-11. doi: 10.1016/j.brachy.2015.09.010. Epub 2015 Nov 7.
3
A comparison of inverse optimization algorithms for HDR/PDR prostate brachytherapy treatment planning.高剂量率/后装近距离放射治疗前列腺癌治疗计划的逆优化算法比较
Brachytherapy. 2015 Mar-Apr;14(2):279-88. doi: 10.1016/j.brachy.2014.09.006. Epub 2014 Oct 22.
4
Investigating the role of constrained CVT and CVT in HIPO inverse planning for HDR brachytherapy of prostate cancer.研究受限连续变量调强(constrained continuous variable technique,constrained CVT)和调强适形(conformal volume therapy,CVT)在前列腺癌 HDR 近距离治疗 HIPO 逆向计划中的作用。
Med Phys. 2019 Jul;46(7):2955-2968. doi: 10.1002/mp.13564. Epub 2019 Jun 5.
5
Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy.比较 IPSA 和 HIPO 反规划优化算法在前列腺 HDR 近距离治疗中的应用。
J Appl Clin Med Phys. 2014 Nov 8;15(6):5055. doi: 10.1120/jacmp.v15i6.5055.
6
[Dosimetric analysis of different optimization algorithms for three-dimensional brachytherapy for gynecologic tumors].[妇科肿瘤三维近距离放疗不同优化算法的剂量学分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Apr 20;44(4):773-779. doi: 10.12122/j.issn.1673-4254.2024.04.20.
7
Dosimetric and Radiobiological Evaluation of Hybrid Inverse Planning and Optimization for Cervical Cancer Brachytherapy.宫颈癌近距离放疗混合逆向计划与优化的剂量学和放射生物学评估
Anticancer Res. 2015 Nov;35(11):6091-6.
8
A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.基于解剖结构的逆向计划与模拟退火和图形优化在高剂量率前列腺近距离治疗中的比较。
Brachytherapy. 2008 Jan-Mar;7(1):12-6. doi: 10.1016/j.brachy.2007.10.001. Epub 2007 Nov 26.
9
Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer.调强适形近距离治疗乳腺癌、宫颈癌和前列腺癌中逆向优化方法与正向优化方法的剂量学比较。
Strahlenther Onkol. 2019 Nov;195(11):991-1000. doi: 10.1007/s00066-019-01513-x. Epub 2019 Sep 3.
10
Comparison of the IPSA and HIPO algorithms for interstitial tongue high-dose-rate brachytherapy.比较 IPSA 和 HIPO 算法在间质舌部高剂量率近距离放射治疗中的应用。
PLoS One. 2018 Oct 4;13(10):e0205229. doi: 10.1371/journal.pone.0205229. eCollection 2018.

引用本文的文献

1
Analysis of treatment planning time and optimization parameters for inverse planning for intracavitary and interstitial brachytherapy in uterine cervical cancer.子宫颈癌腔内及组织间近距离治疗逆向计划的治疗计划时间及优化参数分析
J Appl Clin Med Phys. 2025 Jul;26(7):e70157. doi: 10.1002/acm2.70157.
2
Investigation of Dosimetric Evaluation and Treatment Planning Time of Inverse Planning Optimization in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer.宫颈癌腔内与组织间联合近距离治疗中逆向计划优化的剂量学评估及治疗计划时间研究
Cureus. 2025 May 1;17(5):e83330. doi: 10.7759/cureus.83330. eCollection 2025 May.
3

本文引用的文献

1
A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.基于解剖结构的逆向计划与模拟退火和图形优化在高剂量率前列腺近距离治疗中的比较。
Brachytherapy. 2008 Jan-Mar;7(1):12-6. doi: 10.1016/j.brachy.2007.10.001. Epub 2007 Nov 26.
2
A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?一项关于高剂量率近距离放射治疗对前列腺癌进行强化治疗的前瞻性剂量递增试验:超分割放疗疗效的证据?
Brachytherapy. 2006 Oct-Dec;5(4):256-61. doi: 10.1016/j.brachy.2006.08.007.
3
High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
[Dosimetric analysis of different optimization algorithms for three-dimensional brachytherapy for gynecologic tumors].
[妇科肿瘤三维近距离放疗不同优化算法的剂量学分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Apr 20;44(4):773-779. doi: 10.12122/j.issn.1673-4254.2024.04.20.
4
Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.分析式高剂量率前列腺近距离治疗计划,包括自动导管和同位素选择。
Med Phys. 2023 Oct;50(10):6525-6534. doi: 10.1002/mp.16677. Epub 2023 Aug 31.
5
Comparative analysis of dosimetric and radiobiological models of IPSA and HIPO algorithms in combined intra-cavitary/interstitial brachytherapy for cervical cancer.宫颈癌腔内/组织间插植联合近距离放疗中IPSA和HIPO算法的剂量学与放射生物学模型的比较分析
J Contemp Brachytherapy. 2023 Jun;15(3):212-219. doi: 10.5114/jcb.2023.128894. Epub 2023 Jun 23.
6
Commissioning of GPU-based multi-criteria optimizer combined with plan navigation tools for high-dose-rate brachytherapy.基于图形处理器(GPU)的多标准优化器与高剂量率近距离放射治疗计划导航工具的调试
J Contemp Brachytherapy. 2022 Aug;14(4):379-389. doi: 10.5114/jcb.2022.118995. Epub 2022 Aug 23.
7
Assessment of efficacy in automated plan generation for Varian Ethos intelligent optimization engine.评估瓦里安 Ethos 智能优化引擎自动计划生成的疗效。
J Appl Clin Med Phys. 2022 Apr;23(4):e13539. doi: 10.1002/acm2.13539. Epub 2022 Jan 27.
8
Comparison of two inverse planning algorithms for cervical cancer brachytherapy.两种宫颈癌近距离治疗逆向计划算法的比较。
J Appl Clin Med Phys. 2021 Mar;22(3):157-165. doi: 10.1002/acm2.13195. Epub 2021 Feb 24.
9
Does inverse planning improve plan quality in interstitial high-dose-rate breast brachytherapy?逆向计划是否能提高乳腺组织间高剂量率近距离放射治疗的计划质量?
J Contemp Brachytherapy. 2020 Apr;12(2):166-174. doi: 10.5114/jcb.2020.94584. Epub 2020 Apr 30.
10
Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer.调强适形近距离治疗乳腺癌、宫颈癌和前列腺癌中逆向优化方法与正向优化方法的剂量学比较。
Strahlenther Onkol. 2019 Nov;195(11):991-1000. doi: 10.1007/s00066-019-01513-x. Epub 2019 Sep 3.
高剂量率调强近距离放疗联合外照射放疗治疗前列腺癌:加利福尼亚近距离放疗的10年结果。
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1306-16. doi: 10.1016/j.ijrobp.2004.08.014.
4
Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy.前列腺高剂量率近距离治疗中逆向计划模拟退火与几何优化的比较。
Brachytherapy. 2004;3(3):147-52. doi: 10.1016/j.brachy.2004.05.007.
5
A hybrid evolutionary algorithm for multi-objective anatomy-based dose optimization in high-dose-rate brachytherapy.
Phys Med Biol. 2003 Feb 7;48(3):399-415. doi: 10.1088/0031-9155/48/3/309.
6
Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate.基于解剖结构的逆向计划剂量优化用于前列腺高剂量率后装治疗的早期临床经验。
Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):86-100. doi: 10.1016/s0360-3016(02)02897-3.
7
Multiobjective anatomy-based dose optimization for HDR-brachytherapy with constraint free deterministic algorithms.
Phys Med Biol. 2002 Jul 7;47(13):2263-80. doi: 10.1088/0031-9155/47/13/306.
8
Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function.使用快速模拟退火算法和专用目标函数对前列腺高剂量率近距离放疗进行基于逆向规划解剖结构的剂量优化。
Med Phys. 2001 May;28(5):773-9. doi: 10.1118/1.1368127.
9
Anatomy-based three-dimensional dose optimization in brachytherapy using multiobjective genetic algorithms.
Med Phys. 1999 Sep;26(9):1904-18. doi: 10.1118/1.598697.
10
A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy.一种用于评估近距离放射治疗中植入物质量和剂量规格的适形指数(COIN)。
Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):515-24. doi: 10.1016/s0360-3016(97)00732-3.